Main

The site is operated with the financial support of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation.

The information resource uses recommendation technologies. More detailed

Registered by the Federal Service for Supervision of Communications, Information Technology and Mass Communications. Certificates of registration Certificate of registration: EL № FS 77 - 76208 dated July 8, 2019, Certificate of registration: EL № FS 77 - 72003 dated December 26, 2017.

Фийон отрицает организацию встречи ливанского бизнесмена с Путиным

20 Марта
All results

Live broadcast

World

The media reported the death of 20 people after taking a drug for vasculitis in Japan

Reuters: in Japan, 20 people died after taking a drug for vasculitis

Sat, 05/16/2026 - 06:34

Photo: Global Look Press/Frank Hoermann/SVEN SIMON

Озвучить текст

Select important

Off

About 20 people have died in Japan after using the vasculitis drug Tavneos. This was reported on May 15 by the Reuters news agency with reference to the Japanese pharmaceutical company Kissei Pharmaceutical.

"In Japan, about 20 deaths related to severe liver dysfunction have been reported among patients treated with the Amgen drug for the treatment of rare diseases Tavneos," the publication says.

The news is being updated

Переведено сервисом «Яндекс Переводчик»

To share:

Live broadcast

Subscribe and get the news first

Copyright for the iz.ru portal content visualisation system, as well as for the source data, including texts, photos, audio and video materials, graphic images, other works and trademarks, belongs to "MIC Izvestia" LLC

Partial quotation is possible only with a hyperlink to en.iz.ru

The site is operated with the financial support of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation.

The advertiser is responsible for the content of any advertising materials posted on the portal.

The information resource uses recommendation technologies. More detailed

The news, analytics, forecasts and other materials presented on this website do not constitute an offer or recommendation to buy or sell any assets.

Registered by the Federal Service for Supervision of Communications, Information Technology and Mass Communications. Certificates of registration Certificate of registration: EL № FS 77 - 76208 dated July 8, 2019. , Certificate of registration: EL № FS 77 - 72003 dated December 26, 2017.